Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Reference89 articles.
1. Belloni A, Morgan D, Paris V. Pharmaceutical expenditure and policies: past trends and future challenges. OECD Health Working Papers. 2016;(87):0_1–4,8–73.
2. Garattini L, Curto A, Freemantle N. Pharmaceutical price schemes in Europe: time for a ‘continental’ one? PharmacoEconomics. 2016;34(5):423–6.
3. Kheirandish M, Rashidian A, Kebriaeezade A, Cheraghali AM, Soleymani F. A review of pharmaceutical policies in response to economic crises and sanctions. J Res Pharm Pract. 2015;4(3):115–22.
4. Vogler S, Zimmermann N, Ferrario A, et al. Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI conference. J Pharm Policy Pract. 2016;9:9.
5. Banzi R, Gerardi C, Bertele V, Garattini S. Approvals of drugs with uncertain benefit-risk profiles in Europe. Eur J Intern Med. 2015;26(8):572–84.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献